[1]
N.-M. Cason, P. A. Babeș, E. Béres, and K. Babeș, “THE RELATIVE RISK OF DEVELOPING TYPE 2 DIABETES MELLITUS IN YOUNG ADULTS WITH SCHIZOPHRENIA TREATED WITH DIFFERENT ATYPICAL ANTIPSYCHOTIC”, RJDNMD, vol. 26, no. 4, pp. 445-453, Feb. 2020.